Immuron logo

Immuron share price today

(IMRN)

Immuron share price is $1.96 & ₹166.55 as on 21 Dec 2024, 2.30 'hrs' IST

$1.96

-0.04

(-1.75%)

Market is closed - opens 8 PM, 23 Dec 2024

View live Immuron share price in Dollar and Rupees. Guide to invest in Immuron from India. Also see the sentimental analysis on Indian investors investing in Immuron. Get details on the Indian mutual funds that are investing in Immuron. Get Analyst recommendations and forecasts along with all the Immuron's financials.

Immuron share price movements

  • Today's Low: $1.86
    Today's High: $2.02

    Day's Volatility :7.69%

  • 52 Weeks Low: $1.59
    52 Weeks High: $5.96

    52 Weeks Volatility :73.32%

Immuron Returns

PeriodImmuron LtdIndex (Russel 2000)
3 Months
-20.81%
0.0%
6 Months
-21.6%
0.0%
1 Year
0.51%
0.0%
3 Years
-32.76%
-19.7%

Immuron Key Statistics

in dollars & INR

Previous Close
$1.995
Open
$1.97
Today's High
$2.015
Today's Low
$1.86
Market Capitalization
$11.4M
Today's Volume
$4.4K
52 Week High
$5.96
52 Week Low
$1.59
Revenue TTM
$4.9M
EBITDA
$-5.2M
Earnings Per Share (EPS)
$-0.77
Profit Margin
-141.49%
Quarterly Earnings Growth YOY
0.0%
Return On Equity TTM
-42.92%

How to invest in Immuron from India?

It is very easy for Indian residents to invest directly in Immuron from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Immuron stock in both Indian Rupees (INR) and US Dollars (USD). Search for Immuron or IMRN on the INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Immuron or rupee/ dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Immuron shares which would translate to 0.434 fractional shares of Immuron as of today. Learn more about fractional investing.

Indians can now also easily transfer and add money to their US stocks account via the INDmoney app. Invest in US Stocks from India , including recognised companies like Immuron, in just a few clicks!

Returns in Immuron for Indian investors in Rupees

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

Immuron investment value today

Current value as on today

₹1,02,709

Returns

₹2,709

(+2.71%)

Returns from Immuron Stock

₹513 (+0.51%)

Dollar Returns

₹2,196 (+2.2%)

Indian investors sentiment towards Immuron

83%

Period: Sep 21, 2024 to Dec 20, 2024. Change in 30 Days versus previous period

Search volume for Immuron on INDmoney from India has grown in the last 30 days as on Dec 21, 2024. 83% more investors are searching Immuron in the last 30 days versus the previous period.

Global Institutional Holdings in Immuron

  • Rhumbline Advisers

    0.10%

  • Morgan Stanley - Brokerage Accounts

    0.06%

  • Stephens Consulting LLC

    0.03%

Analyst Recommendation on Immuron

Analyst Forecast on Immuron

What analysts predicted

Upside of 139.26%

Current:

$1.96

Target:

$4.69

Insights on Immuron

  • Price Movement

    In the last 3 months, IMRN stock has moved down by -21.9%
  • IMRN vs ALNY (1 yr)

    In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 35.5% return, outperforming this stock by 35.0%
  • IMRN vs VRTX (3 yr)

    In the last 3 years, Vertex Pharmaceuticals Incorporated has given 23.0% return, outperforming this stock by 54.5%
  • Price to Sales

    ForIMRN every $1 of sales, investors are willing to pay $2.2, whereas for Alnylam Pharmaceuticals, Inc., the investors are paying $14.9 for every $1 of sales.

Immuron Financials in INR & Dollars

FY19Y/Y Change
Revenue
$1.7M
↑ 29.55%
Net Income
$-3.2M
↑ 54.26%
Net Profit Margin
-194.55%
↓ 31.17%
FY20Y/Y Change
Revenue
$1.7M
↑ 5.49%
Net Income
$-2.0M
↓ 37.46%
Net Profit Margin
-115.33%
↑ 79.22%
FY21Y/Y Change
Revenue
$111.3K
↓ 94.21%
Net Income
$-6.4M
↑ 189.12%
Net Profit Margin
-5.8K%
↓ 5645.72%
FY22Y/Y Change
Revenue
$537.9K
↑ 424.91%
Net Income
$-1.8M
↓ 69.15%
Net Profit Margin
-338.62%
↑ 5422.43%
FY23Y/Y Change
Revenue
$1.2M
↑ 135.85%
Net Income
$-2.5M
↑ 46.14%
Net Profit Margin
-209.81%
↑ 128.81%
FY24Y/Y Change
Revenue
$3.3M
↑ 171.67%
Net Income
$-4.6M
↑ 83.2%
Net Profit Margin
-141.49%
↑ 68.32%
Q4 FY22Q/Q Change
Revenue
$412.1K
-
Net Income
$-610.2K
-
Net Profit Margin
-148.08%
-
Q1 FY23Q/Q Change
Revenue
$407.8K
↑ 0.0%
Net Income
$-603.9K
↑ 0.0%
Net Profit Margin
-148.08%
↑ 0.0%
Q2 FY23Q/Q Change
Revenue
$791.2K
↑ 92.91%
Net Income
$-696.4K
↑ 14.66%
Net Profit Margin
-88.01%
↑ 60.07%
Q4 FY23Q/Q Change
Revenue
$2.4M
↑ 100.0%
Net Income
$-2.1M
↑ 100.0%
Net Profit Margin
-88.01%
↑ 0.0%
Q2 FY24Q/Q Change
Revenue
$2.5M
↑ 8.14%
Net Income
$-4.9M
↑ 134.6%
Net Profit Margin
-190.94%
↓ 102.93%
Q3 FY24Q/Q Change
Revenue
$2.5M
↑ 0.0%
Net Income
$-4.9M
↑ 0.0%
Net Profit Margin
-190.94%
↑ 0.0%
FY19Y/Y Change
Profit
$1.2M
↑ 76.87%
FY20Y/Y Change
Profit
$1.3M
↑ 6.38%
FY21Y/Y Change
Profit
$72.3K
↓ 94.82%
FY22Y/Y Change
Profit
$368.0K
↑ 452.77%
FY23Y/Y Change
Profit
$879.5K
↑ 150.07%
FY24Y/Y Change
Profit
$2.2M
↑ 154.88%
Q4 FY22Q/Q Change
Profit
$381.3K
-
Q1 FY23Q/Q Change
Profit
$377.4K
↑ 0.0%
Q2 FY23Q/Q Change
Profit
$530.8K
↑ 39.86%
Q4 FY23Q/Q Change
Profit
$1.6M
↑ 100.0%
Q2 FY24Q/Q Change
Profit
$1.8M
↑ 11.14%
Q3 FY24Q/Q Change
Profit
$1.8M
↑ 0.0%
FY19Y/Y Change
Operating Cash Flow
$-1.2M
↓ 49.01%
Investing Cash Flow
$-1.4K
↓ 62.23%
Financing Cash Flow
$1.4M
↓ 52.68%
FY20Y/Y Change
Operating Cash Flow
$-2.2M
↑ 74.99%
Investing Cash Flow
$-595.0
↓ 56.97%
Financing Cash Flow
$798.0K
↓ 44.09%
FY21Y/Y Change
Operating Cash Flow
$-3.1M
↑ 29.59%
Investing Cash Flow
$2.0K
↓ 397.92%
Financing Cash Flow
$20.2M
↑ 2188.79%
FY22Y/Y Change
Operating Cash Flow
$-1.8M
↓ 37.52%
Investing Cash Flow
$8.3K
↑ 355.98%
Financing Cash Flow
$-29.8K
↓ 100.16%
FY23Y/Y Change
Operating Cash Flow
$-1.7M
↑ 1.83%
Investing Cash Flow
$-1.8M
↓ 22433.47%
Financing Cash Flow
$-30.0K
↑ 5.23%
Q4 FY22Q/Q Change
Operating Cash Flow
$-541.0K
↑ 61.61%
Investing Cash Flow
$-878.6K
↑ 0.0%
Financing Cash Flow
$-7.8K
↑ 7.8%
Q1 FY23Q/Q Change
Operating Cash Flow
$-535.4K
↑ 0.0%
Investing Cash Flow
$-5.9K
↓ 99.32%
Financing Cash Flow
$-7.7K
↑ 0.0%
Q2 FY23Q/Q Change
Operating Cash Flow
$-673.1K
↑ 24.99%
Investing Cash Flow
$-5.9K
↑ 0.0%
Financing Cash Flow
$-7.8K
↓ 0.01%

Immuron Technicals Summary

Sell

Neutral

Buy

Immuron is currently not in a favorable trading position ( SELL ) according to technical analysis indicators.

Immuron Vs Peers

Company Name1 Month6 Month1 Year3 Years5 Years
Immuron Ltd
2.67%
-21.6%
0.51%
-32.76%
-41.54%
Regeneron Pharmaceuticals, Inc.
-5.73%
-34.03%
-17.11%
13.66%
87.56%
Biontech Se
4.48%
30.56%
7.36%
-56.46%
225.6%
Alnylam Pharmaceuticals, Inc.
-0.55%
10.11%
28.49%
30.99%
109.19%
Vertex Pharmaceuticals Incorporated
-11.79%
-16.36%
-1.97%
78.33%
80.59%
Company NameP/E RatioP/B RatioPEG RatioEPSROEROADiv YieldBVPS
Immuron Ltd
NA
NA
0.0
0.0
-0.43
-0.17
NA
0.06
Regeneron Pharmaceuticals, Inc.
17.51
17.51
1.06
45.07
0.17
0.07
NA
272.04
Biontech Se
160.8
NA
0.04
-3.11
-0.02
-0.01
NA
79.73
Alnylam Pharmaceuticals, Inc.
NA
NA
-0.49
-0.19
-15.01
-0.03
NA
0.25
Vertex Pharmaceuticals Incorporated
32.84
NA
1.17
0.55
-0.03
0.12
NA
60.65
Company NameAnalyst ViewMarket Cap5 Years Return %PE RatioProfit Margin
Immuron Ltd
NA
$11.4M
-41.54%
NA
-141.49%
Regeneron Pharmaceuticals, Inc.
Buy
$77.8B
87.56%
17.51
33.61%
Biontech Se
Buy
$26.7B
225.6%
160.8
-15.36%
Alnylam Pharmaceuticals, Inc.
Buy
$30.8B
109.19%
NA
-15.86%
Vertex Pharmaceuticals Incorporated
Buy
$102.1B
80.59%
32.84
-4.51%

About Immuron

immuron ltd is a publicly listed australian biopharmaceutical company focused on oral immunotherapy utilizing polyclonal antibody products that target the human gut immune system and gut microbiome. immuron’s technology platform is capable of developing and producing an orally stable therapeutic as a potential ‘oral targeted therapy’ for various immune mediated and inflammatory disorders, among them: non-alcoholic steatohepatitis (nash) diabetes, colitis, arthritis, inflammatory bowel diseases (ibd), irritable bowel syndrome (ibs), liver fibrosis and other chronic disorders in which the immune system plays a key role in thier pathogenesis. these disorders represent areas of growing and unmet medical need, where oral targeted therapy drugs could offer significant advantages due to the lack of absorption and the high safety profile. immuron has one marketed product, which provides proof of concept for its oral immune technology platform, and a pipeline of products at various stages of cl
Organization
Immuron
Employees
7
CEO
Mr. Steven George Lydeamore CPA, M.B.A.
Industry
Health Technology

Management People of Immuron

NameTitle
Mr. Steven George Lydeamore CPA, M.B.A.
Chief Executive Officer
Dr. Jerry Kanellos Ph.D.
Chief Operating Officer
Mr. Flavio Palumbo
Chief Commercial Officer
Mr. Phillip Allen Hains BBus(Acc), C.A., M.B.A.
CFO & Company Secretary
Mr. David Lyon
Head of Marketing

Important FAQs about investing in Immuron from India :

What is Immuron share price today?

Immuron share price today stands at $1.96, Open: $1.97 ; Previous Close: $2.00 ; High: $2.02 ; Low: $1.86 ; 52 Week High: $5.96 ; 52 Week Low: $1.59. The stock opens at $1.97, after a previous close of $2.00. The stock reached a daily high of $2.02 and a low of $1.86, with a 52-week high of $5.96 and a 52-week low of $1.59.

Can Indians buy Immuron shares?

Yes, Indians can invest in the Immuron (IMRN) from India.

With INDmoney, you can buy Immuron at 0 brokerage. The step-by-step process is as follows:

  • Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
  • Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
  • Once funds are transferred successfully, you can buy Immuron at zero transaction cost.

How can I buy Immuron shares from India?

It is very easy to buy Immuron from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Immuron be purchased?

Yes, you can buy fractional shares of Immuron with INDmoney app.

What are the documents required to start investing in Immuron stocks?

To start investing in Immuron, You will need the following documents:

  • Proof of Identification (PAN, Aadhaar etc)
  • Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.

What are today’s High and Low prices of Immuron

Today’s highest price of Immuron (IMRN) is $2.02.

Today’s lowest price of Immuron (IMRN) is $1.86.

What is today's market capitalisation of Immuron

Today's market capitalisation of Immuron IMRN is 11.4M

What is the 52 Week High and Low Range of Immuron

  • 52 Week High

    $5.96

  • 52 Week Low

    $1.59

What are the historical returns of Immuron?

  • 1 Month Returns

    2.67%

  • 3 Months Returns

    -21.6%

  • 1 Year Returns

    0.51%

  • 5 Years Returns

    -41.54%

Who is the Chief Executive Officer (CEO) of Immuron

Mr. Steven George Lydeamore CPA, M.B.A. is the current Chief Executive Officer (CEO) of Immuron.